SCHEMBL5890969

SCHEMBL5890969

CN(C)S(=O)(=O)c1ccc(-c2ccc(S(=O)(=O)N(C)C)cc2)cc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.64
SMN1; SMN2 Q16637 4/20 0.64
ALDH1A1 P00352 3/20 0.64
HTT P42858 2/20 0.64
PKM P14618 1/20 0.50
HDAC4 P56524 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
KDM4E B2RXH2 2/20 0.47
NPC1 O15118 1/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 1/20 0.47
GFER P55789 1/20 0.47
CA12 O43570 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 2/20 0.46
MAPT P10636 3/20 0.46
KMT2A Q03164 1/20 0.46
KCNH2 Q12809 1/20 0.45
GPR55 Q9Y2T6 1/20 0.45
MCOLN3 Q8TDD5 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5891165 1.00 LMNA (0.64) LMNASMN1; SMN2ALDH1A1HTTPKM
SCHEMBL4073854 0.91 LMNA (0.63) LMNASMN1; SMN2ALDH1A1HTTPKM
SCHEMBL3082587 0.89 CA12 (0.57) LMNASMN1; SMN2ALDH1A1HTTPKM
Hydrochloric Acid SCHEMBL28477859 0.89 LMNA (0.61) LMNASMN1; SMN2ALDH1A1HTTPKM
SCHEMBL694839 0.87 LMNA (0.52) LMNASMN1; SMN2ALDH1A1HTTPKM
SCHEMBL3642059 0.84 CA12 (0.59) SMN1; SMN2ALDH1A1RAB9ACA12CA2
SCHEMBL82589 0.82 MAPT (0.65) LMNASMN1; SMN2ALDH1A1HTTCA12
SCHEMBL3594764 0.82 LMNA (0.61) LMNASMN1; SMN2ALDH1A1HTTPKM
SCHEMBL13575399 0.81 ALDH1A1 (0.49) LMNASMN1; SMN2ALDH1A1HTTPKM
Potassium Ion SCHEMBL1577462 0.80 LMNA (0.59) LMNASMN1; SMN2ALDH1A1HTTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7053173-B2 Polymercaptopolyphenyl and process for preparation thereof JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2006-05-30 US claimed
US-20040092775-A1 Polymercaptopolyphenyl and process for preparation thereof JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2004-05-13 US claimed
US-7053173-B2 Polymercaptopolyphenyl and process for preparation thereof JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2006-05-30 US disclosed
US-20040092775-A1 Polymercaptopolyphenyl and process for preparation thereof JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2004-05-13 US disclosed
EP-1380572-A1 POLYMERCAPTOPOLYPHENYLS AND METHOD FOR SYNTHESIS THEREOF Japan Science and Technology Corporation (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092775-A1 Polymercaptopolyphenyl and process for preparation thereof TMT1A, MSMO1, TST LMNA 2133/4885SMN1; SMN2 2154/4885ALDH1A1 1396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.